Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase EARLY_PHASE1 2

Status

Completed 36Terminated 10Recruiting 8Unknown 7Active not recruiting 5Withdrawn 4

Sponsor Class

OTHER 4NETWORK 2NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other 2Genitourinary 1Breast 1

Conditions

Polycystic Ovary Syndrome 2Obesity 2Radiodermatitis 1Prostatic Neoplasms 1Breast Neoplasms 1

Interventions

Radiotherapy 91pembrolizumab 88Cyclophosphamide 84Gemcitabine 70Cisplatin 70Magnetic Resonance Spectroscopy 65Carboplatin 60Radiosurgery 55Paclitaxel 55Nivolumab 48Dexamethasone 45Bevacizumab 42Biopsy 41Fluorouracil 39durvalumab 37Surveys and Questionnaires 36Docetaxel 36fludarabine 35Doxorubicin 35Radiation 33Oxaliplatin 33Capecitabine 33Rituximab 32fludarabine phosphate 31Leucovorin 31Cytarabine 30Melphalan 29Etoposide 28Pemetrexed 27Irinotecan 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Withdrawn × OTHER × Hydrocortisone × Clear all
NCT05073172 2024-05-06

StrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer Patients

OHSU Knight Cancer Institute

Phase NA Withdrawn
Breast

Breast Neoplasms, Radiodermatitis

NCT01422707 2018-07-19

CBS003

University of Virginia

Phase EARLY_PHASE1 Withdrawn
Other

Obesity, Polycystic Ovary Syndrome

NCT01422733 2018-07-19

Effect of Longer-term Adrenal Suppression Using Low Dose Hydrocortisone on Androgen Overproduction

University of Virginia

Phase EARLY_PHASE1 Withdrawn
Other

Obesity, Polycystic Ovary Syndrome

NCT00559481 2013-02-01

Ketoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy

Roswell Park Cancer Institute

Phase NA Withdrawn
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡